CXCR4 and familial pancreatic carcinoma: Using a cross-disciplinary approach starting with computational modeling of the CXCR4 receptor structure to in vitro analysis of CXCR4 signaling, our study has determined that chloroquine and hydroxychloroquine act as novel CXCR4 inhibitors in pancreatic cancer cells.